The CLEC-2–podoplanin axis controls the contractility of fibroblastic reticular cells and lymph node microarchitecture

Jillian L. Astarita(Harvard University), Shannon J. Turley(California Institute for Regenerative Medicine), Viviana Cremasco(Dana-Farber Cancer Institute), Matthew C. Woodruff(Emory University), Yuji Kondo(Frontier Science Foundation), Burkhard Ludewig(University Hospital of Zurich), Janice M Nieves-Bonilla(Dana-Farber Cancer Institute), Robby M. Weimer(Sunesis (United States)), Alvin Gogineni(Angiogenesis Foundation), Lucas Onder(Kantonsspital St. Gallen), Max Darnell(Harvard University), James R. Peck(Dana-Farber Cancer Institute), Jianxin Fu(Oklahoma Medical Research Foundation), Michael C. Carroll(Boston Children's Hospital), Lijun Xia(Oklahoma Medical Research Foundation), Kai Song(Oklahoma Medical Research Foundation), David Mooney(Harvard University)
Nature Immunology
October 27, 2014
Cited by 284


Related Papers